The PROactive evaluation of function to Avoid Cardio-Toxicity (PROACT; NCT03862131) clinical trial has started at Washington University School of Medicine and Yale New Haven Hospital with patients receiving baseline MyoStrain exams before chemotherapy treatment. The study will evaluate the...
Myocardial Solutions’ MyoStrain was featured in two different posters presented at the European Society of Cardiology's annual Heart Failure Congress 2019. The event was held in Athens, Greece on May 25-28, 2019. The lead author of the abstracts was Dr. Henning Steen, Head of Cardiac Imaging at...
Myocardial Solutions provided MyoStrain cardiac function exams to attendees of the 2019 Hauptstadt Congress for Medicine and Health (Hauptstadt Kongress) in Berlin, Germany from Mary 21st – 23rd. In collaboration with medneo GmbH, Berlin Heart Institute and Philips, MyoStrain provided scan...
Three posters utilizing Myocardial Solutions’ MyoStrain® were presented at the annual European Magnetic Cardiovascular Resonance (EuroCMR) Congress 2019. The event was held in Venice, Italy on May 2-4, 2019. The posters covered the following...
Myocardial Solutions’ MyoStrain was featured in four different abstracts presented at the 85th Annual Conference of the German Society of Cardiology (DGK). The event was held in Mannheim, Germany on April 24th-27th, 2019. The abstracts addressed the multiple uses for MyoStrain across indications...
